PHC summit 2020 registration 
Rydges Wellington Airport - 930 November Friday 27th 

Please note registration is confirmed on receipt of payment.
Registration is limited to 80 in-person participants - first-in-first served.
Confirmation of registration will be emailed in batches weekly.
Please do not be offended if you miss out - you will be refunded ASAP and encouraged to participate online.

The New Zealand Society of Oncology are delighted to invite you to the inaugural personalised health care summit.

Personalised health care or precision medicine is increasingly becoming a part of daily clinical oncology practice and an important component of both clinical and pre-clinical cancer research. This meeting hopes to bring together different perspectives within the Aotearoa/New Zealand consumer, clinician, research and industry cancer community. We hope to foster collaboration towards a unified strategy to ensure those with cancer and their whanau benefit from the opportunities for improvements in outcomes offered by the technologies within personalised health care.

We are delighted Dr Nina Scott (Nga Puhi, Ngati Whatua, Waikato), Dr Donna Cormack (Kāti Mamoe, Kai Tahu) and Irene Kereama-Royal (Hauraki, Ngati Raukawa ki te Tonga and Ngāpuhi) will lead our first session; Data sovereignty and the need to maintain an equity focus.

Assoc Prof Chris Hemmings, Prof Cris Print and Dr Matt Strother will provide background in pathology and data interpretation.

Prof David Thomas will join us via video-link from Australia. Professor Thomas is head of Genomic Cancer Medicine, Garvan Institute of Medical Research, director of the Kinghorn Cancer Centre, chief executive officer of Omico: Australian Genomic Cancer Medicine Centre and conjoint professor St Vincent's Clinical School, Faculty of Medicine, UNSW. His talk is titled "The Australian Genomic Cancer Medicine Centre: a national precision oncology platform. "

The afternoon session will be dedicated to exploring current and future PHC practice in Aotearoa/New Zealand Cancer Care.

This will include Dr Michelle Wilson and Dr Laird Cameron's experience of Tāmaki Makaurau/Auckland based genomics-informed clinical trials and a model molecular tumour board chaired by Dr Ben Lawrence.

We have kept time in the programme for breakout session small group discussion. Please suggest topics on your registration survey. Current suggestions include; real world access/equity, peer-to-peer support for data interpretation/clinical significance.

Question Title

* 1. Personal details

Question Title

* 2. Registration class 
Payment to be forwarded to New Zealand Society of Oncology
Please enter surname in reference field

Question Title

* 3. In person registrants only - dietary requirements

Question Title

* 4. Suggestion for breakout discussion topic regarding personalised health care in cancer care and research in Aotearoa/New Zealand.

0 of 4 answered